News > Deals & Cases > Pharmaceutical Law
  • A world leading pharmaceutical company

    November 12th, 2018

    Kyriakides Georgopoulos Law Firm acted for a world leading pharmaceutical company submitting petitions of annulment before the Council of State: α) against the growth share criterion in vaccines which is included in clawback acts of 2018 and b) against the right of the deduction pharmacies may have from pharma companies, when the former have increased sales in generics.
    Continue reading "A world leading pharmaceutical company " »
  • A global pharma company

    October 16th, 2018

    Kyriakides Georgopoulos Law Firm represented a global pharma company submitting petition of annulment before the Council of State against the imposed clawback acts of 2018.
    Continue reading "A global pharma company " »
  • World leading food company

    May 15th, 2018

    Kyriakides Georgopoulos Law Firm advised a world leading food company on the assessment, development, implementation and monitoring of a compliance program and the creation of operating policies for its Greek affiliate.
    Continue reading "World leading food company" »
  • Medical devices company

    May 07th, 2018

    Kyriakides Georgopoulos Law Firm acted for a medical devices company with regards to the global acquisition of the electrophysiology business of another medical devices company in what regarded the Greek part of the transaction.
    Continue reading "Medical devices company " »
  • Healthcare company

    April 10th, 2018

    Kyriakides Georgopoulos Law Firm acted for a global healthcare company in relation to the sale of its local vaccines and OTC (Over-the-Counter)/consumer healthcare businesses to another pharma company and the purchase by the former of the latter’s local oncology business
    Continue reading "Healthcare company" »
  • World leading pharmaceutical company

    February 06th, 2018

    Kyriakides Georgopoulos Law Firm advised a world leading pharmaceutical company which decided to take the first step and pioneer in restructuring its wholesale network, by reducing its members and enhancing the use of digital means in supplying its products to the market. We rendered legal advice with regards to the design, development and implementation of the re-mapping of the distribution network and successfully represented our client before the Greek courts against several wholesalers who raised claims both with lawsuits, requesting compensation, and petitions for injunction, seeking the continuation of the terminated distributorships.
    Continue reading "World leading pharmaceutical company" »
  • Major pharma companies

    February 06th, 2018

    Kyriakides Georgopoulos Law Firm represented several major pharma companies before the Supreme Court in their judicial attempts against the Greek State with regards to the annulment of payment orders that were issued and based on which the pharma industry was invited to pay rebates and clawbacks imposed by law.
    Continue reading "Major pharma companies" »
  • Global leader in the manufacture of musculoskeletal medical products

    November 09th, 2017

    Kyriakides Georgopoulos Law Firm acted for a global leader in the manufacture of musculoskeletal medical products, with regards to the Greek part of the acquisition of the worldwide trauma business of an Orthopedics company.
    Continue reading "Global leader in the manufacture of musculoskeletal medical products" »
  • Research-based biopharmaceutical company

    November 02nd, 2016

    Kyriakides Georgopoulos Law Firm acted for a research-based biopharmaceutical company with regards to the internal audit of its local affiliate; our services consisted of advising and supporting the general counsel with regards to Greek laws governing interactions of pharmaceutical manufacturers with health care providers and other decision makers as evidenced by data and documents provided via an e-room and as more fully learned in the course of interviews with the managers of the Greek affiliate.

     

    Continue reading "Research-based biopharmaceutical company " »